SCHEMBL23601730

SCHEMBL23601730

CCN(c1cc(F)cc(CCC(C)(C)C(F)(F)F)c1)c1nc2nncn2c2ccc(F)cc12

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23601511 0.82 CRY1 (0.30)
SCHEMBL23601061 0.81 SMN1; SMN2 (0.35) SMN1; SMN2
SCHEMBL23576882 0.80
SCHEMBL29909350 0.80
SCHEMBL23601422 0.79
SCHEMBL23601716 0.77 SMN1; SMN2 (0.30) SMN1; SMN2
SCHEMBL23601771 0.77 SMN1; SMN2 (0.31) SMN1; SMN2
SCHEMBL23601419 0.77 PDE2A (0.31)
SCHEMBL23601581 0.76
SCHEMBL23601672 0.76 MAPT (0.35) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021130638-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS CARNA BIOSCIENCES, INC. (JP) 2021-07-01 WO disclosed